Merck’s new spin-off to focus on infertility treatment

04-Dec-2013 - Germany

Merck Serono announced the creation of TocopheRx, a Boston-based spin-off company resulting from its Entrepreneur Partnership Program (EPP) launched in April 2012. TocopheRx, the 8th spin-off in the EPP will focus on the development of oral follicle-stimulating hormone (FSH) agonists for treatment of infertility, by advancing Merck Serono's preclinical program towards clinical testing. Merck Serono will initially invest $ 3.2 million (approx. € 2.4 million) in seed funding.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances